Mavrilimumab
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Mavrilimumab, covering 2016-09-27 to 2025-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation [Phase 2, Phase 3]